Jefferies Predicts Stellar Outlook For Medivation Inc (MDVN) and MDV3100
Get Alerts MDVN Hot Sheet
Price: $81.44 --0%
Rating Summary:
12 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 2 | New: 35
Rating Summary:
12 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 2 | New: 35
Join SI Premium – FREE
Today Jefferies analysts increased their price target on Medivation, Inc’s (NASAQ: MDVN) from $95 to $97 based on expectation that their cancer drug MDV3100 will reach $2 billion in sales by 2020.
Jefferies analysts are optimistic that drug will continue to do will in clinical trails. MDV3100 has shown positive results in a Phase III trail (AFFIRM) for post-cehmotherapy castrate-resistant prostate cancer (CRPC), and is currently in Phase III (PREVAIL).
Jefferies analysts conducted a proprietary survey involving urologists and oncologists showing strong MDV3100 pre and post-chemo uptake.
Jefferies has a BUY rating Medivation (NASDAQ: MDVN).
For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.
Shares of Medivation closed at $74.82 yesterday.
Jefferies analysts are optimistic that drug will continue to do will in clinical trails. MDV3100 has shown positive results in a Phase III trail (AFFIRM) for post-cehmotherapy castrate-resistant prostate cancer (CRPC), and is currently in Phase III (PREVAIL).
Jefferies analysts conducted a proprietary survey involving urologists and oncologists showing strong MDV3100 pre and post-chemo uptake.
Jefferies has a BUY rating Medivation (NASDAQ: MDVN).
For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.
Shares of Medivation closed at $74.82 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Veradigm Inc (MDRX) to Hold
- System 1 (SST) PT Lowered to $2 at Evercore ISI
- B.Riley Upgrades National CineMedia (NCMI) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!